Inactive Instrument

Chelsea Therapeutics International Ltd. Stock

Stocks

End-of-day quote Nasdaq
- ^USD	-

14-06-12	Chelsea Therapeutics Presents Efficacy and Safety Data for NORTHERA at International Congress of Parkinson's Disease and Movement Disorders	GL
14-05-09	Chelsea Therapeutics : INVESTOR ALERT: Levi & Korsinsky, LLP Announces Investigation of Chelsea Therapeutics International, Ltd. and Its Board of Directors In Connection With the Sale of the Company to H. Lundbeck A/S	BU
14-05-09	Chelsea Therapeutics : Newman Ferrara LLP : Announces Investigation of Chelsea Therapeutics International Ltd.	BU
14-05-08	Chelsea Therapeutics : Law Firm Kirby McInerney LLP Investigating Potential Claims on Behalf of Chelsea Therapeutics International, Ltd. Stockholders	BU
14-05-08	Chelsea Therapeutics : INVESTOR ALERT: Levi & Korsinsky, LLP Announces Investigation of Chelsea Therapeutics International, Ltd. and Its Board of Directors In Connection With the Sale of the Company to H. Lundbeck A/S	BU

14-05-08

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Change	5-day change	1-year change	3-year change	Capi.($)
WUXI APPTEC CO., LTD.	+1.52%	-7.19%	+51.66%	+69.99%	65B
LONZA GROUP AG	+1.52%	+6.83%	+10.77%	+79.30%	51.2B
ARGENX SE	+0.30%	-0.46%	+2.53%	+61.89%	51.19B
IQVIA HOLDINGS INC.	-0.38%	+1.40%	+29.98%	+42.37%	43.93B
BEONE MEDICINES AG	+0.30%	+5.64%	+16.99%	+133.30%	41.96B
REVOLUTION MEDICINES, INC.	+2.35%	-6.08%	+236.69%	+528.10%	38.14B
CELLTRION, INC.	+2.16%	+9.87%	+18.92%	+59.70%	33.24B
WUXI BIOLOGICS (CAYMAN) INC.	+5.50%	-1.37%	+40.57%	+9.65%	25.2B
GENMAB A/S	+1.60%	+2.21%	+21.34%	+28.00%	22.5B
Average	+1.58%	-0.04%	+47.72%	+112.48%	41.37B
Weighted average by Cap.	+1.37%	-0.16%	+46.27%	+113.42%

Employees

Sector